Bulletin
Investor Alert

Seattle Genetics Inc.

NAS: SGEN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 6, 2020, 5:02 p.m.

/zigman2/quotes/203326163/composite

$

161.80

Change

0.00 0.00%

Volume

Volume 88,405

Quotes are delayed by 20 min

/zigman2/quotes/203326163/composite

Previous close

$ 162.59

$ 161.80

Change

-0.79 -0.49%

Day low

Day high

$159.25

$164.17

Open

52 week low

52 week high

$65.44

$187.99

Open

Annual Financials for Seattle Genetics Inc.

Fiscal year is January-December. All values USD millions. 20152016201720182019 5-year trend
Sales/Revenue 336.8M418.15M482.25M654.7M916.71M
Cost of Goods Sold (COGS) incl. D&A 37.44M42.32M54.12M88.29M43.95M
COGS excluding D&A 22.94M24.28M29.85M62.26M10.44M
Depreciation & Amortization Expense 14.51M18.03M24.27M26.03M33.51M
Depreciation 13.7M17.23M23.47M25.33M33.51M
Amortization of Intangibles 805,000800,000800,000700,000-
Gross Income 299.36M375.83M428.13M566.41M872.76M
20152016201720182019 5-year trend
SG&A Expense 420.31M518.56M623.93M817.91M1.09B
Research & Development 294.53M379.31M456.7M565.31M719.37M
Other SG&A 125.78M139.25M167.23M252.6M373.93M
Other Operating Expense -----
Unusual Expense --(33.78M)8.5M-
EBIT after Unusual Expense --(162.02M)(260M)-
Non Operating Income/Expense ---7.34M50.12M
Non-Operating Interest Income 464,0002.61M3.14M6.32M11.77M
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income (120.49M)(140.11M)(158.89M)(246.35M)(158.65M)
Income Tax --(33.36M)(23.65M)-
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (120.49M)(140.11M)(125.53M)(222.69M)(158.65M)
Minority Interest Expense -----
Net Income (120.49M)(140.11M)(125.53M)(222.69M)(158.65M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (120.49M)(140.11M)(125.53M)(222.69M)(158.65M)
Preferred Dividends -----
Net Income Available to Common (120.49M)(140.11M)(125.53M)(222.69M)(158.65M)
EPS (Basic) (0.93)(1.00)(0.88)(1.41)(0.96)
Basic Shares Outstanding 129.18M140.75M143.17M157.66M165.5M
EPS (Diluted) (0.93)(1.00)(0.88)(1.41)(0.96)
Diluted Shares Outstanding 129.18M140.75M143.17M157.66M165.5M
EBITDA (106.45M)(124.69M)(171.53M)(225.47M)(187.03M)
Link to MarketWatch's Slice.